Wellness company Hello Heart has raised $12 million in new funding that will go toward developing at-home monitoring solutions and behavioral treatments for hypertension, TechCrunch reported July 31.

Researchers at the Carnegie Institution for Science, Johns Hopkins University and the Mayo Clinic have reportedly leveraged “state-of-the-art” genome editing to track lipoprotein movement in real time, allowing scientists a glimpse into how cholesterol moves, accumulates and gathers to build plaque.

A study published in JAMA Cardiology July 24 suggests high-intensity statin use after MI depends on where patients live in the U.S., with 66% higher use in New England than in the country’s West South Central region.

Young people who used their smartphone five or more hours per day were 43% more likely to be obese than their counterparts with less reported screen time in a recent study presented at the ACC Latin American Conference 2019 in Cartagena, Colombia.

Australian researchers have uncovered yet another link between the controversial Paleolithic diet and heart disease.

The FDA on July 15 approved Sun Pharmaceutical Industries’ sprinkle formulation of rosuvastatin, an alternative to traditional lipid-lowerers for patients who have difficulty swallowing.

Toward the end of June, around a dozen American diabetics took an 817-mile caravan ride from Minneapolis to London, Ontario, in an effort to obtain more affordable insulin, CBS News reports. It was the second caravan in two months to make the trip.

Abbott Laboratories is planning to increase production of its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the coming years, Reuters reported July 16.